PRECIGEN, INC.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended September 30, 2026, certain of our officers and directors amended or adopted a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K) as follows:
| Name | Date of adoption/modification | Nature of Trading Arrangement | First Eligible Date of Sale | Expected Termination | Aggregate Number of Securities |
|---|---|---|---|---|---|
| Harry Thomasian Jr. Chief Financial Officer | Adoption September 30, 2026 | Trading Plan for sale of common stock | December 29, 2026 | September 30, 2027 | 377,338 |
| Rutul Shah Chief Operating Officer | Adoption September 30, 2026 | Trading Plan for sale of common stock | December 29, 2026 | September 30, 2027 | 140,001 |
| Phil Tennant Chief Commercial Officer | Adoption September 30, 2026 | Trading Plan for sale of common stock | December 29, 2026 | September 30, 2027 | 80,000 |
The Rule 10b5-1 trading arrangements described above were adopted and pre-cleared in accordance with Precigen’s Insider Trading Policy and actual transactions made pursuant to such trading arrangements will be disclosed publicly in future Section 16 filings with the SEC. Other than as disclosed above, no other officer or director adopted, modified orterminated a Rule 10b5-1 trading arrangement or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K) during the three months ended September 30, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.